HISHIPHAGENC INJ. 50A

HISHIPHAGEN-C INJ (히시파겐씨 주)  is an injectable prescription medication imported from Japan (by Nipro Pharma), marketed by GC Wellbeing (Green Cross) in Korea. It's primarily used as a liver function enhancer and an adjuvant therapy for certain allergic skin conditions and drug-related toxicities 

Composition

Mono ammonium glycyrrhizinate (glycyrrhizin derivative): 53 mg per mL (equivalent to ~40 mg glycyrrhizic acid)

L cysteine hydrochloride: 20 mg per mL

Glycine: 400 mg per mL 

Benefits

Liver support: Improves liver enzyme levels in chronic hepatitis and cirrhosis patients, potentially lowering disease progression

Detoxification: L cysteine and glycine aid in metabolizing toxins and drugs 

Anti inflammatory & immune modulating: Effective as an adjunct in urticaria, eczema, allergic dermatoses, and drug-induced skin reactions 

Fatigue and hangover relief: Often known as the “licorice shot,” it’s popularly used for general fatigue and hangover recovery .

Pharmacodynamics

Mono ammonium glycyrrhizinate converts to glycyrrhetinic acid, inhibiting 11β hydroxysteroid dehydrogenase type 2, enhancing cortisol activity and producing anti inflammatory effects.

L cysteine and glycine serve as antioxidants and support hepatic detoxification 

Dosage & Administration

Adults: Intravenous injection of 2–20 mL once daily.

For chronic liver disease: 40–60 mL IV once daily, not to exceed 100 mL/day.

Adjust according to age, symptoms, and severity. Administered via IV bolus or drip

Duration

Treatment duration varies based on clinical response and liver enzyme normalization.

Typically administered once daily over days or weeks, tailored per disease severity and monitoring.

The Pack includes

50 ampules.

*The product has contraindications. We are not responsible for any negative consequences that you may encounter after self-use of the product. Before any procedure, it is recommended to consult a doctor or medical specialist.